Dr. Gina Elhammady, MD

Dr. Elhammady practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.

Dr. Elhammady's NPI, 1760826341, was assigned on April 25, 2013. Dr. Elhammady graduated from Mansoura University Faculty of Medicine in 2003. Dr. Elhammady holds Florida license ME 112986.

Dr. Elhammady's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.

Dr. Elhammady's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Elhammady to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elhammady practices. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Elhammady's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Elhammady is board certified in hematopathology by the American Board of Pathology. Dmand AI has Dr. Elhammady's licenses on file in 15 states: Florida, Illinois, Michigan, Arizona, Iowa, New Jersey, Nevada, Ohio, South Carolina, Texas, Alaska, Arkansas, District of Columbia, Georgia and Idaho.

CMS data shows 41,911 Medicare services from Dr. Elhammady across 23 procedure codes in 2024, for 2,390 Medicare patients. Medicare paid $1,784,546 for them. Every service was in an office.

CMS counts 2,390 Medicare patients who saw Dr. Elhammady in 2024. The largest group is 75 to 84, with 1,037 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elhammady's median patient age at 72, with 53% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Elhammady for performance year 2024, reported as part of a group. Dr. Elhammady accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Elhammady in 2011. Dr. Elhammady's most frequent co-authors are Ted I. Brindle, MD, Barth Armand Green, MD and Jonathan Russell Jagid, MD.

CMS Open Payments shows 15 general payments to Dr. Elhammady from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Adaptive Biotechnologies Corporation paid the most, $281.

Dr. Elhammady graduated from Mansoura University Faculty of Medicine in 2003.

Dr. Elhammady is in network with 13 carriers, including Excellus BlueCross BlueShield, United Healthcare and Cigna. Medicaid plans come from the most carriers, 5. Check the plan with the practice before a visit.